The European Commission says it plans to produce a set of concrete measures to address the supply chain issues that can lead to drug shortages in the EU by the end of this year, under what it calls a “structured dialogue” with stakeholders from the pharmaceutical industry and patient and health professional organizations.
The dialogue, which was launched on 26 February, is the first step in implementing the EU’s Pharmaceutical Strategy, which was...








